AbbVie Inc. is 207.4x more valuable than NEKTAR THERAPEUTICS by market capitalization ($399.47 B vs $1.93 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NKTR | ABBV |
|---|---|---|
| Market cap | $1.93 B | $399.47 B |
| US-listed rank | #2118 | #28 |
| Revenue (latest FY) | $55.23M | $61.16B |
| Net income (latest FY) | -$164.00M | $4.23B |
| Net margin | -296.9% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 1,949 | 1,008 |
AbbVie Inc. is 207.4x more valuable than NEKTAR THERAPEUTICS by market capitalization ($399.47 B vs $1.93 B).
In their latest fiscal years, NEKTAR THERAPEUTICS reported $55.23M in revenue while AbbVie Inc. reported $61.16B.
Full pages: NEKTAR THERAPEUTICS and AbbVie Inc., or browse the full rankings.